With thanks to our conference sponsors and exhibitors

For over 120 years, Teva has been a different kind of biopharmaceutical company – one that operates across the full spectrum of innovation to continuously better health worldwide. 

We do this by following the science to create the medicines needed today; driving the discovery and development of modern therapies; innovating throughout our established portfolio and promising pipeline; leveraging strategic partnerships to accelerate the development of therapies; streamlining the launches of generics and biosimilars through our legacy capabilities.

For healthcare professionals, patients, caregivers and families, we commit to push the boundaries to help deliver quality medicine wherever it is needed, discover life changing treatments and strive forward through scientific innovation.

Because when it comes to health, good is not enough for us. 

THIS is the Teva legacy—to be stronger, bolder and simpler in the way we operate and relentless in our growth by understanding what’s next—in science, for patients, people and society. 

We are all in for better health.

Moving forward together with science that treats, inspired by the people we serve. 

We are Teva. 
 

For further information please visit: www.tevauk.com/

At Novartis, our mission is to discover new ways to improve and extend people’s lives. Discovering new treatments requires imagination and visionary thinking combined with determination and rigour. This happens every day at Novartis.
We are proud of our contribution to medical progress, but there’s still a long way to go. Through the discovery, research and development of innovative treatments and technologies, we aim to tackle devastating diseases and help people in the UK and around the world live longer, better lives.

For further information please visit: https://www.novartis.com/uk-en/